ADx will attend AD/PD2023
ADx is excited to attend AD/PD2023 this year in Gothenburg, Sweden. Find below an overview of posters and presentations from ADx’ and our collaborators.
Besides plasma pTau biomarkers, ADx is also focussing on the development of synaptic biomarkers.
At AD/PD2023, we will present analytical and clinical data from the new ADx prototypes for the measurement of VAMP2, SNAP25 and N-terminal a-synuclein.